
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Neuronetics
Neuronetics, Inc. provides healthcare services. The Company develops therapies for chronic neuro health disorders. Neuronetics serves patients in the United States.
Stock Analysis

last close
$3.18
1-mo return
8.9%
3-mo return
-0.3%
avg daily vol.
311.53T
52-week high
15
52-week low
1.98
market cap.
$85M
forward pe
-
annual div.
-
roe
-38.2%
ltg forecast
-
dividend yield
-
annual rev.
$57M
inst own.
83%